SRDX - Surmodics, Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Surmodics beats top-line and bottom-line estimates; updates FY24 outlook
• Surmodics Non-GAAP EPS of $0.53, revenue of $28M
• Surmodics Non-GAAP EPS of $0.52 beats by $0.98, revenue of $52.5M beats by $14.44M
• Surmodics spikes on FDA nod for SurVeil drug coated balloon
• Surmodics granted FDA nod for Pounce LP clot removal system
• Surmodics upgraded at Needham citing FDA nod for drug coated balloon
• Surmodics files for $200M mixed shelf offering
• Surmodics Non-GAAP EPS of -$0.40 beats by $0.11, revenue of $27.2M beats by $1.34M
• Surmodics stock surges 10% on FDA feedback for drug-coated balloon filing
• Hilton Grand Vacations rallies after S&P MidCap 400 Index callup
• Surmodics downgraded at Needham on uncertainty over drug-coated balloon
• Surmodics Non-GAAP EPS of -$0.50 beats by $0.16, revenue of $24.9M beats by $0.93M
• Surmodics cuts workforce by 13% after FDA declines to approve drug-coated balloon
• Surmodics sinks as FDA declines to approve drug-coated balloon
• Surmodics Non-GAAP EPS of -$0.26 beats by $0.19, revenue of $25.99M beats by $1.9M
• Surmodics gets additional $125M in credit facility
• Surmodics Non-GAAP EPS of -$0.34 beats by $0.04, revenue of $24.9M misses by $0.29M
• Surmodics Non-GAAP EPS of -$0.22 beats by $0.12, revenue of $26.1M beats by $2.13M
• Surmodics hits a 52 week low as Q1 revenue miss expectations
• Surmodics Non-GAAP EPS of -$0.13, revenue of $23M; reaffirms full year guidance